| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |